BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong revenue growth expectations, improved net loss, and positive market trends in authentication solutions. Product developments and strategic focuses align with market needs, and financial health is stable with no funding issues. The Q&A session highlights optimism for future opportunities and a strong pipeline, despite some challenges in U.S. contracts. Overall, the positive elements outweigh the negatives, suggesting a likely positive stock price movement.
Key Financial Performance
Revenue In Q1 '26, revenues increased 34% to $2.1 million versus $1.6 million in Q1 '25. The increase was driven by expanded 1-year software license renewal from a long-time banking customer serving over 30 million clients with biometric identity solutions.
License Fee Revenue License fee revenue increased 24% to $1.4 million. This growth was attributed to the expanded software license renewal.
Hardware Revenue Hardware revenue increased more than 100% to approximately $531,000. This was due to increased purchases of biometric hardware solutions, including sales related to a foreign Defense Ministry and sales from previously fully reserved inventory.
Gross Profit Gross profit grew 33% to $1.8 million in Q1 '26 compared to Q1 '25. The gross margin remained strong at 82%, benefiting from growth in high-margin license fee revenue and sales of fully reserved inventory.
Operating Expenses Operating expenses were approximately $2 million in both Q1 '25 and Q1 '26. Higher R&D expenses were offset by lower SG&A expenses in Q1 '26.
Net Loss Net loss improved to $165,036 or $0.15 per share in Q1 '26, compared to a net loss of $736,545 or $1.57 per share in Q1 '25. The improvement was due to higher revenue and gross profit combined with relatively flat operating expenses.
Book Value Book value was $7.6 million or $7.04 per share as of March 31, 2026, compared to $7.7 million or $7.07 per share at year-end 2025.
Cash and Cash Equivalents Cash and cash equivalents were $2.2 million as of March 31, 2026, compared to $2.7 million as of December 31, 2025.
Accounts Receivable Accounts receivable were $1.6 million as of March 31, 2026, compared to $1.2 million as of December 31, 2025.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Biometric identity and access management solutions: BIO-key has developed a suite of biometric solutions that are gaining traction in defense, financial services, and enterprise markets, particularly in EMEA. The solutions are integrated into DLT's platform to streamline procurement for public sector customers.
PortalGuard IAM and Passkey:YOU: These solutions are being integrated into DLT's offerings to meet Zero Trust digital infrastructure mandates and multifactor authentication requirements.
Market expansion in EMEA, India, and Vietnam: BIO-key is seeing traction in EMEA markets supported by regional distribution partners and favorable regulatory frameworks. New partners in India and Vietnam are expected to drive future opportunities.
Public sector opportunities in the U.S.: Partnership with DLT Solutions enables BIO-key to reach public sector customers more effectively.
Revenue growth: Q1 2026 revenues increased by 34% to $2.1 million, driven by software license renewals and hardware sales.
Gross margin: Maintained a strong gross margin of 82%, benefiting from high-margin license fee revenue and sales of fully reserved inventory.
Subscription-based business model: Approximately 50% of new business is domestic and 100% of international business is through channel partners, ensuring scalability.
Focus on passwordless and biometric authentication: BIO-key is leveraging trends like passwordless authentication and AI-driven threats to position its solutions as essential for secure digital access.
Unified access platforms: The market's shift towards unified access platforms aligns with BIO-key's strengths, targeting workforce, partner, and privileged access needs.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
NASDAQ Suspension: BIO-key's shares were recently suspended from NASDAQ, and while efforts are underway to appeal and return to the NASDAQ capital market, there is uncertainty regarding the success or timing of this process. This could impact investor confidence and the company's stock liquidity.
Regulatory Compliance: The company has not yet completed the review of its financial statements by an independent public accounting firm, which could lead to adjustments and potential regulatory scrutiny.
Dependence on Partners: BIO-key's international business is entirely reliant on channel partners, which poses risks if partners underperform or fail to meet expectations in marketing and sales efforts.
Market Competition: The company operates in a competitive market for biometric identity and access management solutions, which could pressure pricing and market share.
Economic and Geopolitical Risks: Expansion into foreign markets such as India and Vietnam exposes the company to economic and geopolitical uncertainties that could affect operations and revenue.
AI-Driven Threats: The rise of AI-driven cybersecurity threats increases the need for resilient identity strategies, and failure to address these effectively could impact the company's reputation and customer trust.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Q2 2026 Outlook: The company is confident in its first-half outlook and optimistic about the balance of the year and beyond. They expect to maintain or improve their financial position as they approach the end of Q2 2026.
Market Trends and Growth Expectations: The company anticipates continued expansion of digital services and mobile use cases requiring secure authentication. They expect demand for secure digital access to grow due to increasing cybersecurity threats. Passwordless authentication is projected to gain traction and become the standard in the near future. Biometric authentication is expected to see growing adoption in high-value use cases such as military, defense, financial services, and healthcare. The rise of AI-driven threats is expected to escalate the need for resilient identity strategies. The market is moving towards unified access platforms, which aligns with the company's strengths.
Geographic Expansion: The company is seeing solid opportunities in India and Vietnam as new partners ramp up marketing and sales efforts. They are also experiencing traction in EMEA markets supported by strong regional distribution partners and favorable regulatory frameworks.
Partnerships and Strategic Initiatives: The partnership with DLT Solutions is expected to streamline procurement for public sector customers in the U.S., enabling easier adoption of the company's solutions. This partnership is anticipated to support growth in the public sector market.
Financial Projections: The company expects to be profitable and cash flow positive in Q2 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you confirm the timeline for the NASDAQ appeal meeting and the filing of the 10-K?
A:The NASDAQ appeal meeting is scheduled for June 16th. The company expects to file both the 10-K and the Q by the end of the week, aiming to be fully compliant and up-to-date.
Q:Are there any funding issues or distractions affecting growth initiatives or customer discussions due to the NASDAQ situation?
A:No, there are no funding issues or distractions. The company is on solid financial footing, has sufficient funds to operate and invest in growth initiatives, and maintains strong customer relationships.
Q:What is the outlook for the second quarter and the first half of the year?
A:The outlook is strong with better visibility than in the past 2-3 years. The company is targeting larger opportunities and has a strong pipeline for 2026. Several contracts have been awarded but are pending finalization.
Q:Why did hardware revenue increase this quarter, and is this a new trend?
A:The increase in hardware revenue is tied to larger license opportunities requiring significant hardware. The company is selling fully reserved inventory, which contributes to cash flow and margins. Hardware remains a lumpy but integral part of the offering.
Q:What are the growth prospects in education and financial services compared to defense?
A:Education is stable but lacks hyper-growth potential. Financial services, especially with international national banks, show significant growth potential due to the demand for strong authentication solutions.
Q:What is the company's perspective on trends like tokenization, crypto, and quantum technology?
A:The company is cautious about the hype around tokenization and crypto, focusing on real-world solutions. They are investing in quantum-proof encryption but prioritize addressing current needs while preparing for future trends.
Q:What is the cash flow from operations for the first quarter?
A:The company ended the year with $2.7 million in cash and the first quarter with $2.3 million, indicating a back-of-the-envelope cash usage of approximately $400,000.
Q:How much of the hardware sales came from written-off inventory?
A:Approximately $100,000 of hardware sales came from written-off inventory.
Q:Are the inventory sales one-off, or do they include software licensing?
A:The inventory sales include a combination of one-off sales and software licensing. The company expects more significant sales of reserved inventory in Q2 and beyond.
Q:Can prior losses offset profits to avoid taxes if the company becomes profitable?
A:Yes, the company has sufficient net operating losses (NOLs) to offset profits and avoid taxes.
Q:Is it harder to win large U.S. contracts compared to international ones?
A:Yes, U.S. contracts are more challenging due to privacy and regulatory concerns, which are less prevalent internationally. However, the company sees growth opportunities in both markets.
Q:Who are the competitors for global bank and defense contracts, and what is the company's differentiator?
A:The company competes with smaller regional players and MSPs but not major players like Okta or SailPoint. Their differentiator is a comprehensive authentication platform with biometric options and flexibility.
Q:Could the company consider share buybacks or dividends if it starts generating cash?
A:While not currently feasible, the company hopes to consider share buybacks or dividends in the future as it scales and becomes more profitable.
Q:Will legal adviser fees for the NASDAQ hearing impact second-quarter revenue?
A:No, the company does not believe the legal adviser fees will impact second-quarter revenue.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer to the question about the exact cash flow from operations for the first quarter, only offering a rough estimate. Additionally, they did not provide specific competitors' names for global bank and defense contracts, instead focusing on their own differentiators.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
BKYI success
Ceci result
DLT Solutions
DLT kind
DLT platform
DLT sector
EMEA market
IAM Passkey
India Vietnam
Monday Mr
Mr Jones
NASDAQ Today
NASDAQ capital
NASDAQ trading
OTC market
Passkey solution
Solutions division
TD Synnex
access solution
authentication
cybersecurity
defense service
identity access
industry
need
organization
outlook
passwordless
revenue
sector solution
share NASDAQ
threat
traction
use case
work
world
BKYI Transcript
BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
Positive5-18
The earnings call reveals strong revenue growth expectations, improved net loss, and positive market trends in authentication solutions. Product developments and strategic focuses align with market needs, and financial health is stable with no funding issues. The Q&A session highlights optimism for future opportunities and a strong pipeline, despite some challenges in U.S. contracts. Overall, the positive elements outweigh the negatives, suggesting a likely positive stock price movement.
BIO-key International, Inc. (BKYI) Q4 2025 Earnings Call Transcript
Positive3-31
The earnings call highlights improved financial metrics, including increased gross margins and cash position, despite a slight increase in net loss. The Q&A reveals optimistic guidance with potential growth in strategic sectors and regions, supported by partnerships. The announcement of PortalGuard Version 7 and a significant contract renewal further bolster the outlook. While some uncertainties remain, such as the reverse stock split, the overall sentiment leans positive due to strong future prospects and strategic initiatives.
BIO-key International, Inc. (BKYI) Q3 2025 Earnings Call Transcript
Unknown11-14
The earnings call presents a mixed picture. Financial performance shows a slight decline in gross margin and increased net loss, but cash position improved significantly. Product development is positive with new contracts and high-quality offerings. Market strategy is strong with potential expansions and partnerships. However, flat revenues and management's vague responses in the Q&A raise concerns. The strategic plan indicates optimism for future growth, but immediate financial metrics and unclear guidance limit positive sentiment. Overall, the stock reaction is likely neutral in the short term, balancing positive long-term prospects with current challenges.
BIO-key International, Inc. (BKYI) Q2 2025 Earnings Conference Call Transcript
Positive8-13
The earnings call highlights strong revenue growth (49% increase), reduced SG&A expenses, and a significant reduction in note payable. Despite a slight decline in gross margin, the overall financial performance is robust. The Q&A section reveals confidence in future growth, especially in defense and cybersecurity markets. Although management avoided specific guidance, the positive contract activity and expected breakeven achievement provide a positive outlook. The lack of market cap data suggests a neutral to positive reaction, but given the strong financials and growth prospects, a positive sentiment is warranted.
BKYI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
